Advertisement

Thermoablation of Renal Tumors

  • Roshan M. Patel
  • Kamaljot S. Kaler
  • Zhamshid Okhunov
  • Jaime Landman
Chapter

Abstract

In the past several decades, there has been a growing trend in the utilization of minimally invasive treatment options aimed at decreasing the morbidity associated with surgical extirpation of renal tumors. Thermoablation is one such minimally invasive option that has emerged as an alternative treatment for the management of small renal masses. In contemporary practice, this is typically performed using either cryoablation or radiofrequency ablation. Now with long-term data demonstrating similar oncological outcomes to that of surgical extirpation, the role of ablative therapy will most certainly expand in the coming years. Additionally, repeat ablation after primary treatment failure is a reasonable treatment approach with promising medium-term outcomes. In this chapter, we will describe patient selection, surgical techniques, and perioperative outcomes of renal thermoablation. Additionally, we will summarize oncological outcomes and results of salvage cryoablation.

Keywords

Kidney cancer Renal cell carcinoma Cryoablation Radiofrequency ablation Radiation Minimally invasive Ultrasonography Computed tomography Laparoscopy Percutaneous 

References

  1. 1.
    Birkhauser FDKN, Pantuck AJ. Etiology of renal cell carcinoma: incidence, demographics, and environmental factors. In: Campbell SC, Rini BI, editors. Renal cell carcinoma clinical management. Totowa: Humana Press; 2013. p. 1 online resource.Google Scholar
  2. 2.
    Clayman RV, Kavoussi LR, Soper NJ, Dierks SM, Merety KS, Darcy MD, et al. Laparoscopic nephrectomy. N Engl J Med. 1991;324(19):1370–1.PubMedGoogle Scholar
  3. 3.
    McKiernan J, Simmons R, Katz J, Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology. 2002;59(6):816–20.PubMedCrossRefGoogle Scholar
  4. 4.
    Moskowitz D, Chang J, Ziogas A, Anton-Culver H, Clayman RV. Treatment for T1a renal cancer substratified by size: “less is more”. J Urol. 2016;196(4):1000–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol. 2008;179(2):468–71. discussion 72–3PubMedCrossRefGoogle Scholar
  6. 6.
    Winfield HN, Donovan JF, Lund GO, Kreder KJ, Stanley KE, Brown BP, et al. Laparoscopic partial nephrectomy: initial experience and comparison to the open surgical approach. J Urol. 1995;153(5):1409–14.PubMedCrossRefGoogle Scholar
  7. 7.
    Gettman MT, Blute ML, Chow GK, Neururer R, Bartsch G, Peschel R. Robotic-assisted laparoscopic partial nephrectomy: technique and initial clinical experience with DaVinci robotic system. Urology. 2004;64(5):914–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, Chang A, et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017;198:520.PubMedCrossRefGoogle Scholar
  9. 9.
    Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913–24.PubMedCrossRefGoogle Scholar
  10. 10.
    Johnson DC, Vukina J, Smith AB, Meyer AM, Wheeler SB, Kuo TM, et al. Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate. J Urol. 2015;193(1):30–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170(6 Pt 1):2217–20.PubMedCrossRefGoogle Scholar
  12. 12.
    Richard PO, Jewett MA, Bhatt JR, Kachura JR, Evans AJ, Zlotta AR, et al. Renal tumor biopsy for small renal masses: a single-center 13-year experience. Eur Urol. 2015;68(6):1007–13.PubMedCrossRefGoogle Scholar
  13. 13.
    Rosales JC, Haramis G, Moreno J, Badani K, Benson MC, McKiernan J, et al. Active surveillance for renal cortical neoplasms. J Urol. 2010;183(5):1698–702.PubMedCrossRefGoogle Scholar
  14. 14.
    Patel N, Cranston D, Akhtar MZ, George C, Jones A, Leiblich A, et al. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy. BJU Int. 2012;110(9):1270–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Mehrazin R, Smaldone MC, Kutikov A, Li T, Tomaszewski JJ, Canter DJ, et al. Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance. J Urol. 2014;192(3):659–64.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Mues AC, Haramis G, Badani K, Gupta M, Benson MC, McKiernan JM, et al. Active surveillance for larger (cT1bN0M0 and cT2N0M0) renal cortical neoplasms. Urology. 2010;76(3):620–3.PubMedCrossRefGoogle Scholar
  17. 17.
    Arnott J. Practical illustrations of the remedial efficacy of a very low or anaesthetic temperature-I: in cancer. Lancet. 1850;56(1409):257–9.CrossRefGoogle Scholar
  18. 18.
    Copper IS. Cryogenic surgery: a new method of destruction or extirpation of benign or malignant tissues. N Engl J Med. 1963;268:743–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Onik G, Cooper C, Goldberg HI, Moss AA, Rubinsky B, Christianson M. Ultrasonic characteristics of frozen liver. Cryobiology. 1984;21(3):321–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Rewcastle JC, Sandison GA, Saliken JC, Donnelly BJ, McKinnon JG. Considerations during clinical operation of two commercially available cryomachines. J Surg Oncol. 1999;71(2):106–11.PubMedCrossRefGoogle Scholar
  21. 21.
    Uchida M, Imaide Y, Sugimoto K, Uehara H, Watanabe H. Percutaneous cryosurgery for renal tumours. Br J Urol. 1995;75(2):132–6. discussion 6–7PubMedCrossRefGoogle Scholar
  22. 22.
    D'Arsonval M. Action physiologique des courants alternatifs. C R Soc Biol. 1891;43:283–6.Google Scholar
  23. 23.
    Clark W. Oscillatory desiccation in the treatment of accessible malignant growths and minor surgical conditions. J Adv Ther. 1911;29:169–83.Google Scholar
  24. 24.
    Organ LW. Electrophysiologic principles of radiofrequency lesion making. Appl Neurophysiol. 1976;39(2):69–76.PubMedGoogle Scholar
  25. 25.
    McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Investig Radiol. 1990;25(3):267–70.CrossRefGoogle Scholar
  26. 26.
    Rossi S, Fornari F, Pathies C, Buscarini L. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori. 1990;76(1):54–7.PubMedCrossRefGoogle Scholar
  27. 27.
    McGahan JP, Brock JM, Tesluk H, Gu W-Z, Schneider P, Browning PD. Hepatic ablation with use of radio-frequency electrocautery in the animal model. J Vasc Interv Radiol. 1992;3(2):291–7.PubMedCrossRefGoogle Scholar
  28. 28.
    JP MG, Schneider P, Brock JM, Tesluk H. Treatment of liver tumors by percutaneous radiofrequency electrocautery. Semin Interv Radiol. 1993;10(2):143–9. Copyright© 1993 by Thieme Medical Publishers, IncCrossRefGoogle Scholar
  29. 29.
    Zlotta AR, Wildschutz T, Raviv G, Peny MO, van Gansbeke D, Noel JC, et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol. 1997;11(4):251–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology. 1998;37(3):171–86.PubMedCrossRefGoogle Scholar
  31. 31.
    Theodorescu D. Cancer cryotherapy: evolution and biology. Rev Urol. 2004;6(Suppl 4):S9–S19.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Chosy SG, Nakada SY, Lee FT Jr, Warner TF. Monitoring renal cryosurgery: predictors of tissue necrosis in swine. J Urol. 1998;159(4):1370–4.PubMedCrossRefGoogle Scholar
  33. 33.
    Nakada SY, Lee FT Jr, Warner T, Chosy SG, Moon TD. Laparoscopic cryosurgery of the kidney in the porcine model: an acute histological study. Urology. 1998;51(5A Suppl):161–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Nakada SY, Lee FT Jr, Warner TF, Chosy SG, Moon TD. Laparoscopic renal cryotherapy in swine: comparison of puncture cryotherapy preceded by arterial embolization and contact cryotherapy. J Endourol. 1998;12(6):567–73.PubMedCrossRefGoogle Scholar
  35. 35.
    Woolley ML, Schulsinger DA, Durand DB, Zeltser IS, Waltzer WC. Effect of freezing parameters (freeze cycle and thaw process) on tissue destruction following renal cryoablation. J Endourol. 2002;16(7):519–22.PubMedCrossRefGoogle Scholar
  36. 36.
    Campbell SC, Krishnamurthi V, Chow G, Hale J, Myles J, Novick AC. Renal cryosurgery: experimental evaluation of treatment parameters. Urology. 1998;52(1):29–33. discussion –4PubMedCrossRefGoogle Scholar
  37. 37.
    De Filippo M, Bozzetti F, Martora R, Zagaria R, Ferretti S, Macarini L, et al. Radiofrequency thermal ablation of renal tumors. Radiol Med. 2014;119(7):499–511.PubMedCrossRefGoogle Scholar
  38. 38.
    Kwan KG, Matsumoto ED. Radiofrequency ablation and cryoablation of renal tumours. Curr Oncol. 2007;14(1):34–8.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Ramanathan R, Leveillee RJ. Ablative therapies for renal tumors. Ther Adv Urol. 2010;2(2):51–68.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Hsu TH, Fidler ME, Gill IS. Radiofrequency ablation of the kidney: acute and chronic histology in porcine model. Urology. 2000;56(5):872–5.PubMedCrossRefGoogle Scholar
  41. 41.
    Hong K, Georgiades C. Radiofrequency ablation: mechanism of action and devices. J Vasc Interv Radiol. 2010;21(8 Suppl):S179–86.PubMedCrossRefGoogle Scholar
  42. 42.
    Crowley JD, Shelton J, Iverson AJ, Burton MP, Dalrymple NC, Bishoff JT. Laparoscopic and computed tomography-guided percutaneous radiofrequency ablation of renal tissue: acute and chronic effects in an animal model. Urology. 2001;57(5):976–80.PubMedCrossRefGoogle Scholar
  43. 43.
    Zagoria RJ, Hawkins AD, Clark PE, Hall MC, Matlaga BR, Dyer RB, et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol. 2004;183(1):201–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Goldberg SN, Gazelle GS. Radiofrequency tissue ablation: physical principles and techniques for increasing coagulation necrosis. Hepato-Gastroenterology. 2001;48(38):359–67.PubMedGoogle Scholar
  45. 45.
    Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma – a meta-analysis and review. J Urol. 2008;179(4):1227–33. discussion 33–4PubMedCrossRefGoogle Scholar
  46. 46.
    Caputo PA, Ramirez D, Zargar H, Akca O, Andrade HS, O'Malley C, et al. Laparoscopic cryoablation for renal cell carcinoma: 100-month oncologic outcomes. J Urol. 2015;194(4):892–6.PubMedCrossRefGoogle Scholar
  47. 47.
    Camacho JC, Kokabi N, Xing M, Master VA, Pattaras JG, Mittal PK, et al. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience. J Vasc Interv Radiol. 2015;26(5):686–93.PubMedCrossRefGoogle Scholar
  48. 48.
    Hayn MH, Schwaab T, Underwood W, Kim HL. RENAL nephrometry score predicts surgical outcomes of laparoscopic partial nephrectomy. BJU Int. 2011;108(6):876–81.PubMedGoogle Scholar
  49. 49.
    Okhunov Z, Shapiro EY, Moreira DM, Lipsky MJ, Hillelsohn J, Badani K, et al. R.E.N.A.L. nephrometry score accurately predicts complications following laparoscopic renal cryoablation. J Urol. 2012;188(5):1796–800.PubMedCrossRefGoogle Scholar
  50. 50.
    Schmit GD, Thompson RH, Kurup AN, Weisbrod AJ, Boorjian SA, Carter RE, et al. Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors. J Urol. 2013;189(1):30–5.PubMedCrossRefGoogle Scholar
  51. 51.
    Blute ML Jr, Okhunov Z, Moreira DM, George AK, Sunday S, Lobko II, et al. Image-guided percutaneous renal cryoablation: preoperative risk factors for recurrence and complications. BJU Int. 2013;111(4 Pt B):E181–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Vernez SL, Okhunov Z, Kaler K, Youssef RF, Dutta R, Palvanov A, et al. Skin-to-tumor distance predicts treatment failure of T1a renal cell carcinoma following percutaneous cryoablation. Urology. 2017;108:195.PubMedCrossRefGoogle Scholar
  53. 53.
    Chang X, Liu T, Zhang F, Qian C, Ji C, Zhao X, et al. The comparison of R.E.N.A.L., PADUA and centrality index score in predicting perioperative outcomes and complications after laparoscopic radio frequency ablation of renal tumors. J Urol. 2015;194(4):897–902.PubMedCrossRefGoogle Scholar
  54. 54.
    Seideman CA, Gahan J, Weaver M, Olweny EO, Richter M, Chan D, et al. Renal tumour nephrometry score does not correlate with the risk of radiofrequency ablation complications. BJU Int. 2013;112(8):1121–4.PubMedCrossRefGoogle Scholar
  55. 55.
    Gahan JC, Richter MD, Seideman CA, Trimmer C, Chan D, Weaver M, et al. The performance of a modified RENAL nephrometry score in predicting renal mass radiofrequency ablation success. Urology. 2015;85(1):125–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Martin JW, Patel RM, Okhunov Z, Vyas A, Vajgrt D, Clayman RV. Multipoint thermal sensors associated with improved oncologic outcomes following cryoablation. J Endourol. 2017;31(4):355–60.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Rendon RA, Gertner MR, Sherar MD, Asch MR, Kachura JR, Sweet J, et al. Development of a radiofrequency based thermal therapy technique in an in vivo porcine model for the treatment of small renal masses. J Urol. 2001;166(1):292–8.PubMedCrossRefGoogle Scholar
  58. 58.
    Atwell TD, Schmit GD, Boorjian SA, Mandrekar J, Kurup AN, Weisbrod AJ, et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol. 2013;200(2):461–6.PubMedCrossRefGoogle Scholar
  59. 59.
    Pierorazio PM, Johnson MH, Patel HD, Sozio SM, Sharma R, Iyoha E, et al. Management of renal masses and localized renal cancer: systematic review and meta-analysis. J Urol. 2016;196(4):989–99.PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Bhan SN, Pautler SE, Shayegan B, Voss MD, Goeree RA, You JJ. Active surveillance, radiofrequency ablation, or cryoablation for the nonsurgical management of a small renal mass: a cost-utility analysis. Ann Surg Oncol. 2013;20(11):3675–84.PubMedCrossRefGoogle Scholar
  61. 61.
    Tsivian M, Kim CY, Caso JR, Rosenberg MD, Nelson RC, Polascik TJ. Contrast enhancement on computed tomography after renal cryoablation: an evidence of treatment failure? J Endourol. 2012;26(4):330–5.PubMedCrossRefGoogle Scholar
  62. 62.
    Matsumoto ED, Watumull L, Johnson DB, Ogan K, Taylor GD, Josephs S, et al. The radiographic evolution of radio frequency ablated renal tumors. J Urol. 2004;172(1):45–8.PubMedCrossRefGoogle Scholar
  63. 63.
    Pirasteh A, Snyder L, Boncher N, Passalacqua M, Rosenblum D, Prologo JD. Cryoablation vs. radiofrequency ablation for small renal masses. Acad Radiol. 2011;18(1):97–100.PubMedCrossRefGoogle Scholar
  64. 64.
    Rodriguez Faba O, Akdogan B, Marszalek M, Langenhuijsen JF, Brookman-May S, Stewart GD, et al. Current status of focal cryoablation for small renal masses. Urology. 2016;90:9–15.PubMedCrossRefGoogle Scholar
  65. 65.
    Johnson S, Pham KN, See W, Begun FP, Langenstroer P. Laparoscopic cryoablation for clinical stage T1 renal masses: long-term oncologic outcomes at the Medical College of Wisconsin. Urology. 2014;84(3):613–8.PubMedCrossRefGoogle Scholar
  66. 66.
    Kim EH, Tanagho YS, Saad NE, Bhayani SB, Figenshau RS. Comparison of laparoscopic and percutaneous cryoablation for treatment of renal masses. Urology. 2014;83(5):1081–7.PubMedCrossRefGoogle Scholar
  67. 67.
    Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol. 2012;61(6):1156–61.PubMedCrossRefGoogle Scholar
  68. 68.
    Thompson RH, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 2015;67(2):252–9.PubMedCrossRefGoogle Scholar
  69. 69.
    Breda A, Anterasian C, Belldegrun A. Management and outcomes of tumor recurrence after focal ablation renal therapy. J Endourol. 2010;24(5):749–52.PubMedCrossRefGoogle Scholar
  70. 70.
    Patel SR, Abel EJ, Hedican SP, Nakada SY. Ablation of small renal masses: practice patterns at academic institutions in the United States. J Endourol. 2013;27(2):158–61.PubMedCrossRefGoogle Scholar
  71. 71.
    Hegg RM, Schmit GD, Boorjian SA, McDonald RJ, Kurup AN, Weisbrod AJ, et al. Percutaneous renal cryoablation after partial nephrectomy: technical feasibility, complications and outcomes. J Urol. 2013;189(4):1243–8.PubMedCrossRefGoogle Scholar
  72. 72.
    Okhunov Z, Chamberlin J, Moreira DM, George A, Babaian K, Shah P, et al. Salvage percutaneous cryoablation for locally recurrent renal-cell carcinoma after primary cryoablation. J Endourol. 2016;30(6):632–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Roshan M. Patel
    • 1
  • Kamaljot S. Kaler
    • 1
  • Zhamshid Okhunov
    • 1
  • Jaime Landman
    • 1
  1. 1.Department of UrologyUniversity of California, IrvineIrvineUSA

Personalised recommendations